BibTex RIS Kaynak Göster

Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature.

Yıl 2010, Cilt: 7 Sayı: 3, 340 - 344, 01.09.2010

Öz

Kaynakça

  • Reis MAG, Harkins D, Krapcho M et al. SEER cancer sta- tistics review, 1975-2003. Bethesda,MD. National Cancer Institute, 2006.
  • Gerard Lim CC, Yahaya H. Second Report of the National Cancer Registry Cancer Incidence in Malaysia 2003. National Cancer Registry, Malaysia
  • Bouchardy C, Usel M, Verkooijen HM et ak. Changing pat- tern of age specific breast cancer incidence in the Swiss canton of Geneva. Breast Cancer Res Treat 2009;DOI 10.1007/s10549-009-0478-y
  • Rainsbury RM. A patient decline mastectomy. Br J Surg 1999;86:1491-2.
  • Estevez LG, Cuevas JM, Florian AAJ et al. Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: Efficacy and correlation with biological markers in a phase II multicenter trial. Clin Cancer Res 2003;9:686-692.
  • Hind D, Wyld L, Beverley CB, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus); Cocharne data- base Syst Rev 2006;25:CD004272.
  • Oura S, Tamaki T, Hirai I et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007;14;48-54.
  • Verkooijen HM, Fioretta GM, Rapiti E et al. Patients’ re- fusal of surgery strongly impairs breast cancer survival. Ann Surg 2005;242:276-80.
  • Hortobagyi GN, Ames FC, Buzdar AU et al. Management of stage III primary breast cancer with primary chemothera- py, surgery and radiation therapy. Cancer 1988;62:2507-16
  • Bear HD, Anderson S, Brown A et al. The effect on tu- mor response of adding sequential preoperative docetaxel to preoparative doxorubicin and cyclophos- phamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol2003;21:4165-74.
  • Smith IC, Heys SD, Hutcheon AW et al. Neoadjuvant che- motherapy in breast cancer: significantly enhanced re- sponse with docetaxel. J Clin Oncol 2002;20:1456-66.
  • Ring A, Webb A, Ashley S et al. Is surgery necessary af- ter complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 2003;21:4540-5.
  • Foudraine NA, Verhoef LC, Burghouts JT. Tamoxifen as sole therapy for primary breast cancer in the elderly pa- tient. Eur J Cancer 1992;28:900-3.
  • Hind D, Wild L, Reed MW. Surgery with or without tamoxifen versus tamoxifen alone for older women with operable breast cancer: Cocharne Review. Br J Cancer 2007;96:1025-9.
  • Dubois JB, Salomon A, Gary-Bobo J, Gary-Bobo J, Pourquier H, Pujal H. Exclusive radical radiation therapy in breast carcinoma. Radiother Oncol 1991;20:24-9.

Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature.

Yıl 2010, Cilt: 7 Sayı: 3, 340 - 344, 01.09.2010

Öz

-

Kaynakça

  • Reis MAG, Harkins D, Krapcho M et al. SEER cancer sta- tistics review, 1975-2003. Bethesda,MD. National Cancer Institute, 2006.
  • Gerard Lim CC, Yahaya H. Second Report of the National Cancer Registry Cancer Incidence in Malaysia 2003. National Cancer Registry, Malaysia
  • Bouchardy C, Usel M, Verkooijen HM et ak. Changing pat- tern of age specific breast cancer incidence in the Swiss canton of Geneva. Breast Cancer Res Treat 2009;DOI 10.1007/s10549-009-0478-y
  • Rainsbury RM. A patient decline mastectomy. Br J Surg 1999;86:1491-2.
  • Estevez LG, Cuevas JM, Florian AAJ et al. Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: Efficacy and correlation with biological markers in a phase II multicenter trial. Clin Cancer Res 2003;9:686-692.
  • Hind D, Wyld L, Beverley CB, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus); Cocharne data- base Syst Rev 2006;25:CD004272.
  • Oura S, Tamaki T, Hirai I et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007;14;48-54.
  • Verkooijen HM, Fioretta GM, Rapiti E et al. Patients’ re- fusal of surgery strongly impairs breast cancer survival. Ann Surg 2005;242:276-80.
  • Hortobagyi GN, Ames FC, Buzdar AU et al. Management of stage III primary breast cancer with primary chemothera- py, surgery and radiation therapy. Cancer 1988;62:2507-16
  • Bear HD, Anderson S, Brown A et al. The effect on tu- mor response of adding sequential preoperative docetaxel to preoparative doxorubicin and cyclophos- phamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol2003;21:4165-74.
  • Smith IC, Heys SD, Hutcheon AW et al. Neoadjuvant che- motherapy in breast cancer: significantly enhanced re- sponse with docetaxel. J Clin Oncol 2002;20:1456-66.
  • Ring A, Webb A, Ashley S et al. Is surgery necessary af- ter complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 2003;21:4540-5.
  • Foudraine NA, Verhoef LC, Burghouts JT. Tamoxifen as sole therapy for primary breast cancer in the elderly pa- tient. Eur J Cancer 1992;28:900-3.
  • Hind D, Wild L, Reed MW. Surgery with or without tamoxifen versus tamoxifen alone for older women with operable breast cancer: Cocharne Review. Br J Cancer 2007;96:1025-9.
  • Dubois JB, Salomon A, Gary-Bobo J, Gary-Bobo J, Pourquier H, Pujal H. Exclusive radical radiation therapy in breast carcinoma. Radiother Oncol 1991;20:24-9.
Toplam 15 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Olgu Sunumu
Yazarlar

Biswa Mohan Biswal Bu kişi benim

Zainal Muhammad Bu kişi benim

Salmah @win Mar Bu kişi benim

Nor Hayati Othman Bu kişi benim

Mohammad Ali Bu kişi benim

Yayımlanma Tarihi 1 Eylül 2010
Yayımlandığı Sayı Yıl 2010 Cilt: 7 Sayı: 3

Kaynak Göster

APA Biswal, B. M., Muhammad, Z., Mar, S. @., Othman, N. H., vd. (2010). Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature. European Journal of General Medicine, 7(3), 340-344.
AMA Biswal BM, Muhammad Z, Mar S@, Othman NH, Ali M. Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature. European Journal of General Medicine. Eylül 2010;7(3):340-344.
Chicago Biswal, Biswa Mohan, Zainal Muhammad, Salmah @win Mar, Nor Hayati Othman, ve Mohammad Ali. “ Report of Two Cases and Review of Literature”. European Journal of General Medicine 7, sy. 3 (Eylül 2010): 340-44.
EndNote Biswal BM, Muhammad Z, Mar S@, Othman NH, Ali M (01 Eylül 2010) Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature. European Journal of General Medicine 7 3 340–344.
IEEE B. M. Biswal, Z. Muhammad, S. @. Mar, N. H. Othman, ve M. Ali, “ Report of two cases and review of literature”., European Journal of General Medicine, c. 7, sy. 3, ss. 340–344, 2010.
ISNAD Biswal, Biswa Mohan vd. “ Report of Two Cases and Review of Literature”. European Journal of General Medicine 7/3 (Eylül 2010), 340-344.
JAMA Biswal BM, Muhammad Z, Mar S@, Othman NH, Ali M. Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature. European Journal of General Medicine. 2010;7:340–344.
MLA Biswal, Biswa Mohan vd. “ Report of Two Cases and Review of Literature”. European Journal of General Medicine, c. 7, sy. 3, 2010, ss. 340-4.
Vancouver Biswal BM, Muhammad Z, Mar S@, Othman NH, Ali M. Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature. European Journal of General Medicine. 2010;7(3):340-4.